Chemed Corporation <CHE.N>: Oppenheimer raises target price to $590 from $500
CHE•Related News
IonQ completes acquisition of SkyWater Technology for $15 cash plus 0.49 shares per share
IONQ•
Enova report shows 61% of small businesses use AI in Q2 2026
ENVA•
Bit Origin announces shareholder meeting on proposed SANGRIX rebrand
BTOG•
Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement deal
CODX•
SEALSQ launches commercial rollout of Miraex quantum photonics technology after June acquisition
LAES•